Agenda for April 18 meeting

Transparency Commission

12 April 2018 - HAS has posted the agenda for the next scheduled TC meeting.

The Transparency Commission will consider the reimbursement of:

  • Insulin glargine with lixisenatide (Soliqua)
  • Abiraterone acetate (Zytiga)
  • Niraparib tosylate monohydrate (Zejula)
  • Everolimus (Votubia)
  • Cyclopentolate (Skiakol)
  • Glycerol phenylbutyrate (Revicti)
  • Ursodeoxycholic acid (Delursan)

Read TC agenda [French]

Michael Wonder

Posted by:

Michael Wonder